HemaSphere (Jun 2022)

P344: THE DUAL BCL-2 AND BCL-XL INHIBITOR AZD4320 SHOWS ON-TARGET ACTIVITY IN ALL AND ACTS SYNERGISTICALLY WITH MCL-1 INHIBITION

  • M. C. Wichert,
  • A. Niedermayer,
  • S. Enzenmüller,
  • K.-M. Debatin,
  • L. H. Meyer,
  • F. Seyfried

DOI
https://doi.org/10.1097/01.HS9.0000844264.32857.90
Journal volume & issue
Vol. 6
pp. 244 – 245

Abstract

Read online

No abstracts available.